Exclusive

Publication

Byline

Location

US Patent Issued to CITY OF HOPE on June 2 for "Hinge-modified IgG antibody compositions for protease resistance and fc-Gamma receptor binding and methods of making the same" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,942, issued on June 2, was assigned to CITY OF HOPE (Duarte, Calif.). "Hinge-modified IgG antibody compositions for protease resistance and ... Read More


US Patent Issued to OTSUKA PHARMACEUTICAL on June 2 for "Anti-GDF15 antibody" (Japanese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,943, issued on June 2, was assigned to OTSUKA PHARMACEUTICAL Co. LTD. (Tokyo). "Anti-GDF15 antibody" was invented by Shigeki Nishihara (Osak... Read More


US Patent Issued to IPROGEN BIOTECH on June 2 for "Antibody-payload conjugates with enhanced delivery domain and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,944, issued on June 2, was assigned to IPROGEN BIOTECH INC. (Burnaby, Canada). "Antibody-payload conjugates with enhanced delivery domain an... Read More


US Patent Issued to Genentech on June 2 for "Apolipoprotein L1-specific antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,945, issued on June 2, was assigned to Genentech Inc. (South San Francisco, Calif.). "Apolipoprotein L1-specific antibodies and methods of u... Read More


US Patent Issued to NB HEALTH LABORATORY, THE UNIVERSITY OF TOKYO on June 2 for "Antibody, nucleic acid, cell, and pharmaceutical" (Japanese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,946, issued on June 2, was assigned to NB HEALTH LABORATORY Co. LTD. (Hokkaido, Japan) and THE UNIVERSITY OF TOKYO (Tokyo). "Antibody, nucle... Read More


US Patent Issued to The Regents of the University of California on June 2 for "Anti-ROR-2 antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,947, issued on June 2, was assigned to The Regents of the University of California (Oakland, Calif.). "Anti-ROR-2 antibodies and methods of ... Read More


US Patent Issued to Nanjing GenScript Biotech on June 2 for "Anti-PD-L1/anti-LAG-3 multiple antigen binding proteins and methods of use thereof" (Chinese, Singaporean Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,948, issued on June 2, was assigned to Nanjing GenScript Biotech Co. Ltd. (Nanjing, China). "Anti-PD-L1/anti-LAG-3 multiple antigen binding ... Read More


US Patent Issued to Gritstone bio on June 2 for "Multi-specific antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,949, issued on June 2, was assigned to Gritstone bio Inc. (Emeryville, Calif.). "Multi-specific antibodies and methods of use" was invented ... Read More


US Patent Issued to Takeda Pharmaceutical on June 2 for "Autoinjector comprising high concentration formulation of vedolizumab" (Massachusetts Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,950, issued on June 2, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "Autoinjector comprising high concentration formulatio... Read More


US Patent Issued to CYTOMX THERAPEUTICS on June 2 for "Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,951, issued on June 2, was assigned to CYTOMX THERAPEUTICS INC. (South San Francisco, Calif.). "Matrix metalloprotease-cleavable and serine ... Read More